Early Access — free while we kick the tires
EdgarHawk

Gawlick Rainer

Director

Director
2 filings analyzed · 2 companies · Latest 2025-08-13

Companies

Company Buys Sells Direction
PROGRESS SOFTWARE CORP /MA PRGS 1 0 Net buying
Proto Labs Inc PRLB 1 0 Net buying

Activity

August 2025
medium
Buy
1,710 shares
$74,351
Significance 5/10

PRGS Director Gawlick Rainer bought 1,710 shares at $43.48; stock down 34.0% from 52-week high, currently $46.11

Gawlick Rainer purchased 1,710 shares of PROGRESS SOFTWARE CORP /MA at $43.48, bringing his holdings to 55,544 shares. The transaction occurred when the stock was trading 34.0% below its 52-week high of $69.89 and has declined 26.4% over the past 90 days. The company has a P/E of 34.41 against a $2.0B market cap, with recent quarterly revenue of $237,400,000 and 8.5% annual growth. This represents the director's first discretionary open-market purchase on record across all tickers tracked. While the purchase coincides with significant price weakness, the company maintains positive earnings and steady revenue growth.

2025-08-07 Proto Labs Inc PRLB
low
Buy
1,715 shares
$75,105
Significance 4/10

Director Gawlick Rainer purchases 1,715 shares of PRLB at $43.79; stock now at $46.29 vs. +13.7% in 30 days

Director Rainer purchased 1,715 shares at $43.79, increasing his holdings to 43,883 shares (+4.1% net change). The stock has appreciated 13.7% over the past 30 days and 14.3% over 90 days, currently trading at $46.29—near the 52-week high of $46.29. While the purchase represents a director-level open-market buy, it occurs in the context of elevated valuation metrics (P/E of 74.66) and muted fundamentals (revenue growth of -0.6% annually, net income of $4.4M on $135.1M revenue). The transaction size is modest relative to his existing position, and the timing follows sharp recent price appreciation, leaving the strategic intent unclear.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access